Europe’s medical devices industry saw a drop of 37.50% in deal activity during August 2022, when compared with the last 12-month average, led by Azenta’s $468.22m acquisition of B Medical Systems, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
A total of 25 medical devices industry deals worth $861.1m were announced for the region in August 2022, against the 12-month average of 40 deals.
Of all the deal types, M&A saw most activity in August 2022 with 12 transactions, representing a 48% share for the region.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataIn second place was venture financing with nine deals, followed by private equity deals with four transactions, respectively capturing a 36% and 16% share of the overall deal activity for the month.
In terms of value of deals, M&A was the leading category in Europe’s medical devices industry with $795.55m, while venture financing and private equity deals totalled $34.36m and $31.18m, respectively.
Europe medical devices industry deals in August 2022: Top deals
The top five medical devices deals accounted for 95.7% of the overall value during August 2022.
The combined value of the top five medical devices deals stood at $823.85m, against the overall value of $861.1m recorded for the month.
The top five medical devices industry deals of August 2022 tracked by GlobalData were:
1) Azenta’s $468.22m acquisition deal with B Medical Systems
2) The $170m acquisition of Curiosity Diagnostics by Bio-Rad Laboratories
3) Eurobio Scientific’s $137.14m acquisition deal with Genome Diagnostics
4) The $31.18m private equity of Pharma Tech Holding by LDA capital
5) 908 Devices’s $17.3m acquisition deal with TRACE Analytics